Measurement of change in estimated glomerular filtration rate in patients with renal insufficiency after contrast-enhanced computed tomography: A case-control study

Journal of Computer Assisted Tomography

Volumn 33, Issue 3, 2009, Pages 455-459

  Bansal, Gaurav Jyoti ^a,b   Darby, Michael ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Contrast enhanced computed tomography; Creatinine; EGFR; Renal impairment

Indexed keywords

COMPUTERIZED TOMOGRAPHY; CONCURRENCY CONTROL;

CASE-CONTROL STUDY; CONTRAST-ENHANCED; CONTRAST-ENHANCED COMPUTED TOMOGRAPHY; CONTROL GROUPS; EGFR; GLOMERULAR FILTRATION RATE; INTRAVENOUS CONTRAST; MEAN VALUES; MEASUREMENTS OF; RENAL IMPAIRMENT;

CREATININE;

CONTRAST MEDIUM; CREATININE; IODIXANOL; IOPROMIDE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; RANK SUM TEST; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CONTRAST MEDIA; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE; MALE; MIDDLE AGED; RENAL INSUFFICIENCY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67649105306     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e31818160a3     Document Type: Article

References (42)

1. Cohan RH, Dunnick NR. Intravascular contrast media: adverse reactions. Am J Roentgenol. 1987;149:665-670.
2. Nah K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39:930-936.
3. Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast media. N Engl J Med. 2006;354:379-386.
4. Morcos SK. Contrast media-induced nephrotoxicity - questions and answers. Br J Radiol. 1998;71:357-365.
5. Thomsen HS, Morcos SK. In which patients should serum creatinine be measured before iodinated contrast media administration? Eur Radiol. 2005;15:749-752.
6. Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors, and preventive strategies. Can Med Assoc J. 2005;172:1461-1471.
7. Chalmers N, Jackson RW. Comparison of iodixanol and iohexol in renal impairment. Br J Radiol. 1999;72:701-703.
8. Becker C, Reiser MF. Use of iso-osmolar nonionic dimer contrast media in multidetector row CT angiography for patients with renal impairment. Invest Radiol. 2005;40:672-675.
9. Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol, and furosemide in acute decreases in renal function induced by radio-contrast agents. N Engl J Med. 1994;331:1416-1420.
10. Merten G, Burgess W, Gray L, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized control trial. JAMA. 2004;291:2328-2334.
11. Tepel M, Zidek W. Acetylcysteine and contrast media nephropathy. Curr Opin Nephrol Hypertens. 2002;11:503-506.
12. Tepel M, Van der giet M, Schwarzfeld C, et al. Prevention of radiographic contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343:180-184.
13. Traynor J, Mactier R, Geddes C, et al. How to measure renal function in clinical practice. BMJ. 2006;333:733-737.
14. Komenda P, Zalunardo M, Burnett S, et al. Conservative outpatient renoprotective protocol in patients with low eGFR undergoing contrast angiography: a case series. Clin Exp Nephrol. 2007;11:209-213.
15. Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl. 2006;100:S11-S15.
16. Schrader R. Contrast material-induced renal failure: an overview. J Interv Cardiol. 2005;18:417-423.
17. Traynor J, Mactier R, Geddes C. How to measure renal function in clinical practice. BMJ. 2006;333:733-737.
18. Bachorzewska GH, Malyszko J, Kralisz P, et al. Estimation of renal function in patients with normal serum creatinine undergoing primary percutaneous coronary intervention. Pol Arch Med Wewn. 2006;115:125-130.
19. Cramer BC, Parfrey PS, Hutchison TA, et al. Renal function following infusion of radiologic contrast material: a prospective controlled study. Arch Intern Med. 1985;145:87-89.
20. Wyman RM, Safian RD, Portway W, et al. Current complication of diagnostic and therapeutic cardiac catheterization. J Am Coll Cardiol. 1988;12:1400-1406.
21. Barrett BJ, Parfrey PS. Clinical practice: preventing nephropathy induced by contrast media. N Engl J Med. 2006;354:379-386.
22. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259-2264.
23. Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors, and preventative strategies. Can Med Assoc J. 2005;172:1461-1471.
24. Waybill MM, Waybill PN. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol. 2001;12:3-9.
25. Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 hours of interventional coronary procedures in patients with preexistent renal insufficiency. J Am Coll Cardiol. 2000;36:1542.
26. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997;103:368-375.
27. Heller CA, Knapp J, Halliday J, et al. Failure to demonstrate contrast nephrotoxicity. Med J Aust. 1991;155:329-332.
28. Levey AS, et al. Effects of dietary protein restriction on the progression of moderate renal disease in the modification of diet in renal disease study. J Am Soc Nephrol. 1996;7:2616-2626.
29. Levey AS, Adler S, Caggiula AW, et al. Effects of dietary protein restriction on the progression of advanced renal disease in the modification of diet in renal disease study. Am J Kidney Dis. 1996;27:652-663.
30. Peterson JC, Adler S, Burkart JM, et al. Blood pressure control, proteinuria, and the progression of renal disease: the modification of diet in renal disease study. Ann Intern Med. 1995;123:754-762.
31. Klahr S, Levey AS, Beck GJ, et al. The effect of dietary protein control and blood pressure control on the progression of chronic kidney disease: modification of diet in renal disease study group. N Engl J Med. 1994;330:877-884.
32. Levey AS, Greene T, Kusek JW, et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:A0828.
33. Mahajan S, Mukhiya GK, Singh R, et al. Assessing glomerular filtration rate in healthy Indian adults: a comparison of various prediction equations. J Nephrol. 2005;18:257-261.
34. Verhave JC, Fesler P, Ribstien J, et al. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis. 2005;46:233-241.
35. Zuo L, Ma YC, Zhou YH, et al. Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Am J Kidney Dis. 2005;45:463-472.
36. Rao QA, Newhouse JH. Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology. 2006;239:392-397.
37. Moore RD, Steinberg EP, Powe NR, et al. Nephrotoxicity of high osmolality versus low osmolality contrast media: randomized control trial. Radiology. 1992;182:649-655.
38. Harris KG, Smith TP, Cragg AH, et al. Nephrotoxicity from contrast material in renal insufficiency: ionic versus nonionic agents. Radiology. 1991;179:849-852.
39. Davidson CJ, Hlatky M, Morris KG, et al. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. Ann Intern Med. 1989;110:119-124.
40. Schwab SJ, Hlatky MA, Pieper KS, et al. Contrast nephrotoxicity: a randomized control trial of a nonionic and ionic contrast agent. N Engl J Med. 1989;320:149-153.
41. Billstrom A, Hietala SO, Lithner F, et al. Nephrotoxicity of contrast media in patients with diabetes mellitus. Acta Radiol. 1989;30:509-515.
42. Katzberg RW, Barret BJ. Risk of iodinated contrast media - induced nephropathy with intravenous administration. Radiology. 2007;243:622-628.